article

Formulation Development & Drug Delivery In-Depth Focus 2017

Posted: 22 February 2017 | | No comments yet

Understanding the effect of API changes in pharmaceutical processing; Improving the consistency of MDI drug delivery; and Expert Views with DDF Summit and Eurofins Lancaster Laboratories…

Formulation In-Depth Focus 2017
  • Understanding the effect of API changes in pharmaceutical processing
    John Gamble, John Jones and Mike Tobyn, Bristol-Myers Squibb
  • Improving the consistency of MDI drug delivery
    David Lewis, Chiesi Ltd
  • Expert View
    With DDF Summit
  • Expert View
    With Eurofins Lancaster Laboratories

This Formulation Development & Drug Delivery In-Depth Focus is restricted to logged-in members. Login or become a member now (it's free!) to read it.


Send this to a friend